Tag Archives: agn

Allergan Expands Aesthetics Line With Kythera Buyout

Allergan (AGN), the specialty-drug giant formerly known as Actavis, said Wednesday that it’s acquiring biotech Kythera (KYTH) for $2.1 billion in cash and stock, sending both stocks up in early trading. Just seven weeks ago, Kythera won FDA approval of its first product, Kybella, an injection for “submental fullness,” i.e. double chin. The original Allergan, which Actavis acquired in March before changing its name on Monday, was best known for its

3 IBD 50 Stocks That Gained On Big News This Week

This past week, several top-rated IBD 50 stocks saw big gains on notable news. Watch this video for more information. Stocks mentioned include: Valeant Pharmaceuticals (VRX), Salix Pharmaceuticals (SLXP), Allergan (AGN), Actavis (ACT), Ulta Beauty (ULTA), Dollar Tree (DLTR), Family Dollar (FDO) and Dollar General (DG). Follow Alissa Williams on Twitter: @IBD_AWilliams. Related: Valeant Mulls Higher Salix Bid, But Don’t Expect $170.

Actavis Tops Views, Announces Name Change To Allergan

Shares of Actavis set a new high but then reversed direction in early trading Wednesday after the Irish drugmaker topped quarterly sales and profit views, helped by a big rise in sales of branded drugs. Actavis (ACT) also said that it will change its name to Allergan (AGN) after its $66 billion buyout of the Botox maker closes later this year. That deal, announced in November, is the third-biggest health care acquisition ever in the U.S.,